[{"AccountsPayableCurrent_0_Q1_USD":1617000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":6000.0,"PrepaidExpenseAndOtherAssets_0_Q1_USD":2567000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1112000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":936000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":308134000.0,"NonoperatingIncomeExpense_1_Q1_USD":936000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":3813000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q1_USD":135000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":1297000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":1372000.0,"OperatingLeasesRentExpenseNet_1_Q1_USD":400000.0,"OtherAssetsNoncurrent_0_Q1_USD":1440000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2358000.0,"ShareBasedCompensation_1_Q1_USD":1350000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":429000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":692000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-15294000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":6000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-100000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":281000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":311640000.0,"IncreaseDecreaseInDeferredLiabilities_1_Q1_USD":-90000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1084000.0,"EquityMethodInvestments_0_Q1_USD":876000.0,"AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation_1_Q1_USD":1350000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-16552000.0,"DeferredRentCreditCurrent_0_Q1_USD":370000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-0.37,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":1009000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9727000.0,"OperatingExpenses_1_Q1_USD":16130000.0,"AdditionalPaidInCapital_0_Q1_USD":396453000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5486209.0,"Assets_0_Q1_USD":317408000.0,"AssetsCurrent_0_Q1_USD":313642000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":311075000.0,"CommonStockSharesIssued_0_Q1_shares":43003733.0,"CommonStockSharesOutstanding_0_Q1_shares":43003733.0,"CommonStockValue_0_Q1_USD":4000.0,"Depreciation_1_Q1_USD":70000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6403000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1037000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1142000.0,"Liabilities_0_Q1_USD":9274000.0,"OperatingIncomeLoss_1_Q1_USD":-16130000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":317408000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":6000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-160000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16398000.0,"NetIncomeLoss_1_Q1_USD":-15294000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":160000.0,"ProfitLoss_1_Q1_USD":-15294000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":885000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-88323000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":41789120.0,"AccruedLiabilitiesCurrent_0_Q1_USD":6595000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"LiabilitiesCurrent_0_Q1_USD":8582000.0,"RestrictedCashNoncurrent_0_Q1_USD":565000.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200512"}]